rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
1.Available evidence confirms that the LRRK2 variant rs34637584 is associated with less cognitive impairment in people with PD.2.GBA variants rs76763715 and rs421016 are associated with more severe cognitive impairment in people with PD.3.The GBA variants rs76763715, rs421016, rs387906315 and rs80356773 have been significantly associated with the onset of depressive symptoms in PD.
|
31292011 |
2020 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
We detected modest PD risk variant p.N409S (rs76763715) in one case, p.E365K (rs2230288) in 12 cases, and p.T408 M (rs75548401) in seven cases, one of whom also had p.E365K.
|
31809948 |
2020 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Our results suggest an association between the GBA c.1226A>G; p.N370S and c.1448T>C; p.L444P mutations and the development of PD in the population of patients from the Northern Brazil.
|
30810589 |
2019 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Using high-resolution, single-cell transcriptomic analyses of iPSC-derived dopamine neurons carrying the GBA-N370S PD risk variant, we identified a progressive axis of gene expression variation leading to endoplasmic reticulum stress.
|
30503143 |
2019 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
To overcome these biases, we traced 13 Gaucher disease (GD) patients who were compound heterozygotes for one mild (N370S) and one severe GBA mutation and who reported a parent with PD.
|
27864021 |
2018 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Pathogenic mutations in the glucocerebrosidase (GBA) gene are associated with Parkinson's disease (PD), of which L444P and N370S are the most frequently observed in patients with PD.
|
29530815 |
2018 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Moreover, α-syn tetramers and related multimers are decreased in N370S <i>GBA1</i> Parkinson's disease (PD) induced pluripotent stem cell (iPSC)-derived human dopaminergic (hDA) neurons and murine neurons carrying the heterozygous L444P <i>GBA1</i> mutation.
|
29311330 |
2018 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The frequency of GBA mutations (L444P, N370S) in PD patients was higher compared to controls (odds ratio [OR] = 6.9, 95% confidence interval [CI], 0.9-53.13, p = 0.031), particularly in patients with early-onset compared to late-onset PD (OR = 3.90 [95% CI, 1.2-13.2], p = 0.009).
|
30146349 |
2018 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease.
|
28779532 |
2017 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Using newly generated GD/PD mouse lines of either sex [<i>Gba</i> mutant (N370S, L444P, KO) crossed to α-synuclein transgenics], we show that <i>Gba</i> mutations predispose to PD through a loss-of-function mechanism.
|
28847804 |
2017 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The p.N370S and p.L444P variants in GBA contributed to a relative risk of 3.8 in early-onset PD and 2.5 in late-onset PD.
|
29029963 |
2017 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Moreover, both L444P and N370S were associated with increased </span>PD risk.
|
26868973 |
2016 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The most common mutations of N370S and L444P accounted for 36.0% (9/25) of all the GBA mutations in this Eastern Canadian PD cohort.
|
26000814 |
2016 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
We studied a set of monozygotic twins harboring the heterozygous glucocerebrosidase mutation (GBA N370S) but clinically discordant for PD.
|
25456120 |
2014 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
There were 14 GD+PD patients: all Ashkenazi Jewish; 11 males (78.6%); mean (range) age diagnosed GD 34.2 (5-62) years; 50% N370S homozygous; mild to moderate GD; 3 asplenic and only these have osteonecrosis; 5 received ERT; mean age (range) diagnosed PD was 57.8 (43-70) years; first PD sign was tremor in 9 (64.3%); cognitive dysfunction in all.
|
25111979 |
2014 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
There is evidence to suggest that PD risk is greater (1) in GBA1 heterozygotes with non-N370S GBA1 mutations compared to N370S mutations and (2) in GD type 1 (GD1) patients compared to GBA1 heterozygotes.
|
22968580 |
2013 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The N370S and R120W mutations were detected in neither the PD group nor the control subjects.
|
23227814 |
2012 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The p.L444P mutation, but not p.N370S and p.R120W, was found to be associated with PD.
|
23286447 |
2012 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Genotyping of p.K-26R, p.K186R and the common p.N370S in an ethnically matched series consisting of 395 patients with PD and 372 control subjects did not show a statistically significant association (P>0.05).
|
19945510 |
2010 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Although PD cases (1.8%) had an increased frequency of N370S compared to controls (0.7%), the difference was not statistically significant (P = 0.290).
|
20528910 |
2010 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The N370S allele (nt.1226 A>G) may be associated with PD in patients of Jewish ethnicity and should be examined in a larger study.
|
15517591 |
2005 |
rs76763715
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Thirty-one patients with Parkinson's disease (31.3 percent; 95 percent confidence interval, 22.2 to 40.4 percent) had one or two mutant GBA alleles: 23 were heterozygous for N370S, 4 were heterozygous for 84GG, 3 were homozygous for N370S, and 1 was heterozygous for R496H.
|
15525722 |
2004 |